Test Price
2,800 AED✅ Home Collection Available
EEF2 Gene Spinocerebellar Ataxia Type 26 (SCA26) Autosomal Dominant Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين EEF2 لمرض الضمور النخاعي المخيخي من النوع 26 (SCA26) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / ملخص تنفيذي
99.9% Diagnostic Sensitivity via ISO 9001:2015 certified processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid Hospital-Grade Home Collection with cold-chain transport and VIP Mobile Phlebotomy (8 AM – 11 PM).
Telephonic Post-Test Clinical Guidance included. Direct Insurance Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: تحليل جيني فائق الدقة لجين EEF2 مسؤول عن الرنح النخاعي المخيخي الوراثي السائد، بموثوقية 99.9% وخدمات سحب منزلي معتمدة بتقنية التبريد وفق معيار ISO 9001:2015.
Test Overview
This Next‑Generation Sequencing (NGS) test analyzes the entire coding region of the EEF2 gene to detect pathogenic variants causing Spinocerebellar Ataxia Type 26 (SCA26), an adult‑onset autosomal dominant neurodegenerative disorder. The test provides a definitive molecular diagnosis, guides neurological management, and enables accurate family risk assessment. يفحص الاختبار كامل الجين EEF2 بتقنية السَلسَلة من الجيل التالي لتشخيص الرنح النخاعي المخيخي من النوع 26.
| Feature | Our Test (DHA‑Accredited) | Closest Alternative (Conventional Lab) |
|---|---|---|
| Technology | Next‑Generation Sequencing (NGS) – full gene analysis | Sanger sequencing of selected exons only |
| Detection Rate | >99.9% for coding variants (ACMG classification) | ~85% (misses deep intronic and copy‑number variants) |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Pre‑test Genetic Counselling | Mandatory, via DHA‑licensed genetic counsellor (pedigree chart included) | Often not provided |
| UAE Regulatory Compliance | Full compliance with Federal Decree‑Law No. 41 of 2024, CDS Law 2026 (minors), PDPL | May lack current DHA/MOHAP accreditation |
Physician Insight & Safety Protocol
“This test offers clarity for families living with the uncertainty of inherited ataxia. A molecular diagnosis of SCA26 empowers targeted neurological follow‑up and informed reproductive choices. However, a negative result does not exclude all genetic ataxias – I strongly advise correlation with clinical imaging and neurophysiology.”
— Dr. Prabhakar Reddy, DHA License 61713011
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide informed consent; unavailable biological family history; severe coagulopathy precluding venipuncture.
- Exclusion: Age < 16 years without legal guardian consent (as per UAE CDS Law 2026 for minors).
- ER Red Flags: Sudden gait deterioration, dysphagia with aspiration risk, acute loss of consciousness – proceed to nearest emergency department immediately.
- ER Red Flags: New‑onset seizures or respiratory distress in a known SCA26 patient.
Patient FAQ & Clinical Guidance
Q1: Why is the EEF2 gene DNA test critical for ataxia diagnosis?
This NGS panel provides definitive confirmation of SCA26 by detecting pathogenic EEF2 variants, ending the diagnostic odyssey for progressive cerebellar ataxia in adults. A positive result enables precise prognosis, cascade family testing, and avoidance of unnecessary immunosuppressive therapies.
ج: يُعد تحليل جين EEF2 حاسماً لأنه يؤكد تشخيص الرنح النخاعي المخيخي من النوع 26، مما يوقف رحلة التشخيص الطويلة ويسمح بفحص أفراد العائلة وتجنب العلاجات غير الضرورية.
س2: ما أنواع العينات المقبولة وكيف يتم جمعها؟
We accept whole blood (EDTA tube), extracted DNA, or a single drop of blood on an FTA card – all collected by our DHA‑licensed mobile phlebotomist at your home or office. The sample is transported in ISO‑validated cold‑chain packaging to maintain DNA integrity.
ج: نقبل عينة دم كامل أو حمض نووي مستخلص، أو نقطة دم واحدة على بطاقة FTA، ونجمعها عبر خدمة السحب المنزلي المتنقلة المرخصة من هيئة الصحة بدبي مع سلسلة تبريد معتمدة.
Q3: How do I interpret the results, and what support is provided?
A comprehensive report classifies variants per ACMG guidelines (Pathogenic, Likely Pathogenic, VUS) and is delivered alongside a 30‑minute tele‑consultation with our genetic counsellor. We also assist in scheduling a follow‑up with your neurologist for immediate clinical integration; WhatsApp +971545488731.
ج: يُقدم التقرير تصنيفاً دقيقاً للطفرات وفق معايير ACMG، مع استشارة وراثية هاتفية لمدة 30 دقيقة، إضافة إلى المساعدة في ترتيب موعد مع طبيب الأعصاب المعالج.
UAE Regulatory & Compliance Guarantee
This service strictly adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87) on genetic data confidentiality, the 2026 CDS Law for protection of minors, and the UAE Personal Data Protection Law (PDPL). Our laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and is audited biannually by DHA/MOHAP. All data is encrypted and stored on UK‑based, GDPR‑compliant servers; no third‑party sharing without explicit patient consent.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians